The Role of Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Reducing Cardiovascular Events in Patients with Type 2 Diabetes-Reference-Cited by-同舟云学术

The Role of Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Reducing Cardiovascular Events in Patients with Type 2 Diabetes

Published:2019 Issue:2 Volume:34 Page:106
ISSN:2093-596X
Container-title:Endocrinology and Metabolism
language:en
Short-container-title:Endocrinol Metab

Author:

Kim Gwang Sil¹²,Park Joong Hyun³,Won Jong Chul¹²^ORCID

Affiliation:

1. Department of Internal Medicine, Inje University Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea.

2. Cardiovascular and Metabolic Disease Center (CMDC), Inje University, Busan, Korea.

3. Department of Neurology, Inje University Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea.

Funder

National Research Foundation of Korea

Publisher

Korean Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://synapse.koreamed.org/pdf/10.3803/EnM.2019.34.2.106

Reference71 articles.

1. Global estimates of diabetes prevalence for 2013 and projections for 2035

2. Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes

3. Trends in All-Cause and Cardiovascular Disease Mortality Among Women and Men With and Without Diabetes Mellitus in the Framingham Heart Study, 1950 to 2005

4. Utilization of glucose, blood pressure, and lipid lowering medications among people with type II diabetes in the United States, 1999–2010

5. 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effects of dipeptidyl peptidase-4 inhibitors on cardiac structure and function using cardiac magnetic resonance: a meta-analysis of clinical studies;Frontiers in Endocrinology;2024-09-11

2. Association between underweight and risk of heart failure in diabetes patients;Journal of Cachexia, Sarcopenia and Muscle;2024-01-14

3. Switch to gliflozins and biventricular function improvement in patients with chronic heart failure and diabetes mellitus;Clinical Physiology and Functional Imaging;2023-10-27

4. Effects of Incretin-Based Treatment on the Diastolic (Dys)Function in Patients with Uncontrolled Type 2 Diabetes Mellitus: A Prospective Study with 1-Year Follow-Up;Diagnostics;2023-08-31

5. Paradigm Shift in Management of Hyperglycemia in Patients with Type 2 Diabetes: Glucocentric versus Organ Protection;The Journal of Korean Diabetes;2023-06-30